Despite the utilization of digital rectal examination (DRE) in clinical practice to detect prostate cancer, there is currently no evidence indicating that DRE alone or in conjunction with the PSA test results in a reduction in prostate cancer mortality [46]. This evidence concerns the gene KLK3 and prostate carcinoma.